
FDA Approves Record-Breaking 59 Novel Drugs in 2018
FDA Approves Record-Breaking 59 Novel Drugs in 2018
Σκοπός του Ιntelligence-pharma είναι να σας ενημερώνει για τις τελευταίες τάσεις και αναλύσεις σχετικά με τον ταχέως μεταβαλλόμενο κόσμο του φαρμάκου.
FDA Approves Record-Breaking 59 Novel Drugs in 2018
Companies Note Collaborations, Financing and Clinical Trial Success
When 2019 Rolls Around, Drug Companies Are Planning Price Hikes on Many Medicines
Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
Top 25 Biotech Companies of 2018
Πώς βλέπει η φαρμακοβιομηχανία την επέκταση της Amazon στην υγεία
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
J&J’s Tremfya Superior to Novartis’ Cosentyx in Head-to-Head Trial
Top 9 Really Cool Life Science Discoveries of the Year
Drugmakers vie to capture slice of rheumatoid arthritis market
Record-Setting Pace for New Drug Approvals in 2018
Pharm Exec’s 2019 Pipeline Report
Εγκρίθηκε νέα θεραπεία για την ημικρανία
Step off our ‘doughnut hole’ deal: AARP ads take on Big Pharma lobbying
AbbVie staves off 6th Humira biosimilar in US
New AHA/ACC Cholesterol Treatment Guideline Expands Role of LDL Targets